pulmonary arterial hypertension

DENVER (MedPage Today) -- Two drugs that are beneficial in heart disease were ineffective in treating pulmonary arterial hypertension (PAH), a researcher said.

(University of California - San Diego) Researchers at the University of California, San Diego, have identified a key protein that promotes the development of pulmonary arterial hypertension in humans and mice.

This groundbreaking discovery has implications for future drug therapies that may extend the life of patients with pulmonary arterial hypertension and prevent the need for lung transplantation, currently the only cure for this debilitating disease.

New rules for lung allocation have increased the likelihood of patients receiving a transplant, but a new study showed that one group did not benefit from reduced mortality (MedPage Today) -- those with with idiopathic pulmonary arterial hypertension (IAPH).